Latest News & Insights
Stay Up to Date with Our Community
Featured
Financing led by institutional investors, with participation from new investor Eli Lilly and Company
Financing led by institutional investors, with participation from new investor Eli...
Phase 1 study of REX-8756 is well underway following FDA clearance...
Recludix Pharma Bolsters Scientific Advisory Board with Acclaimed Leaders in the...
Proceeds will fund a global pivotal trial of lead product candidate,...
The SURPASS study is enrolling patients at research sites across the...
ELA026 has demonstrated promising potential as a frontline treatment for patients...
Proceeds to support continued clinical advancement of lead program, VGA039, a...
ROC-101 exhibits favorable pharmacokinetics for once-daily dosing
Funding to advance first-in-class pan-ROCK inhibitor through Phase 2a testing in...